These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan. Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729 [TBL] [Abstract][Full Text] [Related]
9. Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06. Livermore DM; Hope R; Brick G; Lillie M; Reynolds R; J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii55-63. PubMed ID: 18819980 [TBL] [Abstract][Full Text] [Related]
11. Global reprogramming of virulence and antibiotic resistance in Maunders EA; Triniman RC; Western J; Rahman T; Welch M J Biol Chem; 2020 Nov; 295(48):16411-16426. PubMed ID: 32943550 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of 228 non-fermenting gram-negative rods to tigecycline and six other antimicrobial drugs. Gómez-Garcés JL; Aracil B; Gil Y; Burillo A J Chemother; 2009 Jun; 21(3):267-71. PubMed ID: 19567346 [TBL] [Abstract][Full Text] [Related]
13. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Chuanchuen R; Beinlich K; Hoang TT; Becher A; Karkhoff-Schweizer RR; Schweizer HP Antimicrob Agents Chemother; 2001 Feb; 45(2):428-32. PubMed ID: 11158736 [TBL] [Abstract][Full Text] [Related]
14. Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa. Baum EZ; Crespo-Carbone SM; Morrow BJ; Davies TA; Foleno BD; He W; Queenan AM; Bush K Antimicrob Agents Chemother; 2009 Jul; 53(7):2785-90. PubMed ID: 19433554 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203 [TBL] [Abstract][Full Text] [Related]
16. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. Poole K J Mol Microbiol Biotechnol; 2001 Apr; 3(2):255-64. PubMed ID: 11321581 [TBL] [Abstract][Full Text] [Related]
17. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Zhang L; Li XZ; Poole K Antimicrob Agents Chemother; 2000 Feb; 44(2):287-93. PubMed ID: 10639352 [TBL] [Abstract][Full Text] [Related]
18. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model. Adamson DH; Krikstopaityte V; Coote PJ J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513 [TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteins. Mima T; Joshi S; Gomez-Escalada M; Schweizer HP J Bacteriol; 2007 Nov; 189(21):7600-9. PubMed ID: 17720796 [TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. Wolter DJ; Smith-Moland E; Goering RV; Hanson ND; Lister PD Diagn Microbiol Infect Dis; 2004 Sep; 50(1):43-50. PubMed ID: 15380277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]